Effect Observation and Influencing Factors Analysis of Rapid Initiation of Antiretroviral Therapy

Bo TIAN; Jun LIU; Chongxi LI; Wei ZHANG; Meiqin FANG; Haiyun CHEN; Jingping BAI; Xin ZHOU; Lei CHENG; Yongmei JIN

doi:10.12259/j.issn.2095-610X.S20240925

Volume 45 Issue 9

Sep. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2024 > 45(9): 163-167

Bo TIAN, Jun LIU, Chongxi LI, Wei ZHANG, Meiqin FANG, Haiyun CHEN, Jingping BAI, Xin ZHOU, Lei CHENG, Yongmei JIN. Effect Observation and Influencing Factors Analysis of Rapid Initiation of Antiretroviral Therapy[J]. Journal of Kunming Medical University, 2024, 45(9): 163-167. doi: 10.12259/j.issn.2095-610X.S20240925

Citation:

Bo TIAN, Jun LIU, Chongxi LI, Wei ZHANG, Meiqin FANG, Haiyun CHEN, Jingping BAI, Xin ZHOU, Lei CHENG, Yongmei JIN. Effect Observation and Influencing Factors Analysis of Rapid Initiation of Antiretroviral Therapy[J]. Journal of Kunming Medical University, 2024, 45(9): 163-167. doi: 10.12259/j.issn.2095-610X.S20240925

Citation:

Bo TIAN, Jun LIU, Chongxi LI, Wei ZHANG, Meiqin FANG, Haiyun CHEN, Jingping BAI, Xin ZHOU, Lei CHENG, Yongmei JIN. Effect Observation and Influencing Factors Analysis of Rapid Initiation of Antiretroviral Therapy[J]. Journal of Kunming Medical University, 2024, 45(9): 163-167. doi: 10.12259/j.issn.2095-610X.S20240925

PDF( 563 KB)

Effect Observation and Influencing Factors Analysis of Rapid Initiation of Antiretroviral Therapy

doi: 10.12259/j.issn.2095-610X.S20240925

Dept. of Infection One，The 3rd People’s Hospital of Kunming/Yunnan Clinical Medical Center for Infectious Diseases，Kunming Yunnan 650041，China

Received Date: 2024-04-17
Available Online: 2024-08-20
Publish Date: 2024-09-25

Abstract

Abstract

Objective To investigate the efficacy of 48 weeks of rapid initiation of HIV antiviral therapy in Kunming, and analyze the influencing factors of Non-rapid initiation. Methods Data of patients initially receiving HIV antiviral treatment in The Third People's Hospital of Kunming from January 2018 to December 2022 were retrospectively collected. The time interval between diagnosis and treatment initiation was ≤7 days in the rapid ART group, and > 7 days in the non-rapid ART group. Chi-square test and T-test were used to compare the baseline demographic and clinical characteristics between the two groups and logistic regression analysis was used to analyze the influence factors. The chi-square test was used to compare the difference of CD4 count, viral inhibition rate, cohort retention rate and mortality between the two groups after 48 weeks of treatment. Results The Rapid ART rate was 32.70%, the Non-rapid ART group has higher loss rate in 48 week（χ² = 11.169, P = 0.001）, higher mortality（χ² = 3.924, P = 0.048）. The risk of Non-rapid initiation was 1.212 times higher in patients without a spouse（P = 0.040）. The risk of Non-rapid initiation in patients transmitted by intravenous drug use was 2.987 times that of heterosexual transmission（P < 0.001）. Patients with baseline CD4/CD8<0.5 had a 1.423 times greater risk of Non-rapid initiation than patients with CD4/CD8≥0.5（P = 0.001）, patients with CD4 counts≤350/μL were at higher risk for Non-rapid initiation（P = 0.047）. After 48 weeks of treatment, the virus inhibition rate in the Rapid ART group was higher than that in theNon-rapid ART group（P = 0.031）, the proportion of patients with CD4/CD8≥0.5 was higher in theRapid ART group（P < 0.001）. Conclusion Rapid initiation of antiviral therapy is beneficial to improve viral inhibition rate and cohort retention rate, and reduce mortality. For patients without spouses, with intravenous transmission and CD4/CD8<0.5, more interventions should be given to help patients receive antiviral therapy as soon as possible.
- HIV,
- AIDS,
- ART,
- Rapid ART,
- Early,
- Effect

FullText(HTML)

References(19)

References

[1]	World Health Organization,Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy[G]. July 2017. Geneva: World Health Organization, 2017.ISBN-13: 978-92-4-155006-2. Licence: CC BY-NC-SA 3.0 IGO. Available at: https://www.who.int/publications/who-guidelines.
[2]	Ford N,Migone C,Calmy A,et al. Benefits and risks of rapid initiation of antiretroviral therapy[J]. AIDS,2018,32(1):17-23. doi: 10.1097/QAD.0000000000001671
[3]	Colasanti J,Sumitani J,Mehta C C,et al. Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the Southern United States[J]. Open Forum Infect Dis,2018,5(6):ofy104. doi: 10.1093/ofid/ofy104
[4]	Wu Z,Zhao Y,Ge X,et al. Simplified HIV testing and treatment in China: Analysis of mortality rates before and after a structural intervention[J]. PLoS Med,2015,12(9):e1001874. doi: 10.1371/journal.pmed.1001874
[5]	代丽丽,陈仁芳,陈耀凯,等. 快速启动艾滋病抗病毒治疗专家共识[J]. 中国艾滋病性病,2023,29(7):737-744.
[6]	中华医学会感染病学分会艾滋病丙型肝炎学组中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版)[J]. 中国艾滋病性病,2021,27(11):1182-1201.
[7]	魏来,赵燕,甘秀敏,等. 我国HIV感染者抗病毒治疗及时性分析(2011—2020)[J]. 国际流行病学传染病学杂志,2022,49(6):365-370. doi: 10.3760/cma.j.cn331340-20220928-00196
[8]	Huang Y C,Sun H Y,Chuang Y C,et al. Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: real-world experience from a single-centre retrospective cohort in Taiwan[J]. BMJ Open,2019,9(9):e33246.
[9]	Coffey S,Bacchetti P,Sachdev D,et al. RAPID antiretroviral therapy: High virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population[J]. AIDS,2019,33(5):825-832. doi: 10.1097/QAD.0000000000002124
[10]	马静,罗云学,陈勇志,等. 云南省两州市异性性传播HIV感染者确诊后即治疗影响因素[J]. 中国艾滋病性病,2019,25(12):1211-1214.
[11]	Katirayi L,Namadingo H,Phiri M,et al. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: A qualitative study[J]. J Int AIDS Soc,2016,19(1):20919. doi: 10.7448/IAS.19.1.20919
[12]	马迪辉. 重庆市静脉注射吸毒人群艾滋病疫情的SIR模型[D]. 重庆: 第三军医大学,2015.
[13]	孟聪. 艾滋病防治对毒品政策转型的影响和启示[D]. 北京: 中国人民公安大学,2021.
[14]	Yue Y,Wang N,Han Y,et al. A higher CD4/CD8 ratio correlates with an ultralow cell-associated HIV-1 DNA level in chronically infected patients on antiretroviral therapy: a case control study[J]. BMC Infect Dis,2017,17(1):771. doi: 10.1186/s12879-017-2866-y
[15]	Calin R,Hamimi C,Lambert-Niclot S,et al. Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir[J]. AIDS,2016,30(5):761-769. doi: 10.1097/QAD.0000000000000987
[16]	Labhardt N D,Ringera I,Lejone T I,et al. Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: The CASCADE randomized clinical trial[J]. JAMA,2018,319(11):1103-1112. doi: 10.1001/jama.2018.1818
[17]	周筑,蒋继泽,符燕华,等. 快速启动抗反转录病毒治疗对HIV/AIDS患者病毒学抑制的影响[J]. 传染病信息,2023,36(4):336-340. doi: 10.3969/j.issn.1007-8134.2023.04.009
[18]	Zhao Y,Wu Z,McGoogan J M,et al. Nationwide cohort study of antiretroviral therapy timing: treatment dropout and virological failure in China,2011-2015[J]. Clin Infect Dis,2019,68(1):43-50. doi: 10.1093/cid/ciy400
[19]	Koenig S P,Dorvil N,Devieux J G,et al. Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial[J]. PLoS Med,2017,14(7):e1002357. doi: 10.1371/journal.pmed.1002357

Relative Articles(20)

Relative Articles

[1]	Mengjun LIU, Shoukun CHEN, Liuxin HAN, Jing PENG, Weisha ZHOU, Yunying ZHANG, Yiying WANG, Jiawei XIA. Efficacy of Roxadustat in the Maintenance Hemodialysis of HIV/AIDS Patients Resistant to EPO. Journal of Kunming Medical University, 2024, 45(8): 139-144. doi: 10.12259/j.issn.2095-610X.S20240820
[2]	Xuelin XIANG, Hongrui ZHAO, Zhongjie WANG, Yu XIA, Min MA, Huadan WANG, Liping. HE. Social Support Status and Influencing Factors of HIV-infected Patients on Antiviral Therapy. Journal of Kunming Medical University, 2024, 45(9): 156-162. doi: 10.12259/j.issn.2095-610X.S20240924
[3]	Lanzhu YAN, Shunyi QIAO, Yanli ZHANG, Erqiang ZHAO, Hu YANG, Jing LIN, Haiyan FU. Changes of Immunoglobulin in TACE Treatment of Hepatocellular Carcinoma and Its Value in Predicting Curative Effect. Journal of Kunming Medical University, 2024, 45(4): 128-134. doi: 10.12259/j.issn.2095-610X.S20240418
[4]	Bo TIAN, Yongmei JIN, Haiwen LI, Chongxi LI, Wei ZHANG, Wei GUAN, Haiyun CHEN, Qi XUE, Huirong YANG, Jun LIU. Analysis of the Current Status and Influencing Factors of Metabolic Syndrome in Patients Undergoing Antiretroviral Therapy for AIDS. Journal of Kunming Medical University, 2024, 45(11): 149-154. doi: 10.12259/j.issn.2095-610X.S20241121
[5]	Yihan LIU, Jun LIU, Yongmei JIN, Bo TIAN, Jinsong BAI. Risk Assessment and Analysis of Risk Factors for Cardiovascular Disease in HIV Antiviral Therapy Patients. Journal of Kunming Medical University, 2024, 45(10): 140-146. doi: 10.12259/j.issn.2095-610X.S20241022
[6]	Xiaohua LU, Hongxin YUAN. The Analysis of the Correlation between BTLA，CTLA-4 Gene Polymorphisms and the Efficacy and Prognosis of TACE Combined Targeted Therapy for Liver Cancer. Journal of Kunming Medical University, 2023, 44(9): 126-135. doi: 10.12259/j.issn.2095-610X.S20230927
[7]	Bo TIAN, Chongxi LI, Yongmei JIN, Wei GUAN, Haiyun CHEN, Jun LIU. Use and Replacement of Treatment Regimens for AIDS Patients on Antiretroviral Therapy. Journal of Kunming Medical University, 2023, 44(5): 162-167. doi: 10.12259/j.issn.2095-610X.S20230508
[8]	Diandian ZENG, Bo TIAN, Yongmei JIN, Chongxi LI, Fen TENG, Jun LIU. A Cross-sectional Survey on Quality of Life of AIDS Patients with Different Antiretroviral Regimens in Kunming Area. Journal of Kunming Medical University, 2022, 43(12): 147-152. doi: 10.12259/j.issn.2095-610X.S20221227
[9]	Bo TIAN, Jun LIU, Haiwen LI, Wei SONG, Haiyun CHEN, Jianjun SUN. Pathogen Distribution and Antimicrobial Susceptibility of Bacterial Bloodstream Infection in AIDS Patients. Journal of Kunming Medical University, 2022, 43(6): 140-146. doi: 10.12259/j.issn.2095-610X.S20220616
[10]	Le ZHANG, Yuanqiang HE, Jiawei XIA, Shu LIU, Bin BAI, Xing LIU. Effect of Early Interventional Therapy with Bronchoscopic Alveolar Lavage on AIDS Patients Complicated with Severe Pneumonia. Journal of Kunming Medical University, 2022, 43(11): 151-155. doi: 10.12259/j.issn.2095-610X.S20221120
[11]	Bo TIAN, Yinzhong SHEN, Jinsong BAI, Jun LIU, Haiyun CHEN, Jianjun SUN. Clinical Characteristics of Talaromyces Marneffei Disease and Disseminated Nontuberculosis Mycobacterium Disease in AIDS Patients. Journal of Kunming Medical University, 2022, 43(7): 140-144. doi: 10.12259/j.issn.2095-610X.S20220718
[12]	You-ling LONG, Deng PAN, Tian-zhen XIONG, Yue PAN, Yong SU, Lin XIONG, Yan WU, Ying LI. Clinical Application of Vectorcardiogram in Diagnosis of Left Ventricular Abnormalities in Hypertension. Journal of Kunming Medical University, 2021, 42(4): 113-116. doi: 10.12259/j.issn.2095-610X.S20210421
[13]	Shan HUANG, Song-qin LV, Hong-fen DUAN, Jin-li SHI, Guang-min LI, Gang HUANG, Jia-neng LI, Xiao-fei LI. Cohort Study on the Influence of Opportunistic Infectious Pathogens on the Distribution of Peripheral Blood T Lymphocyte Subsets in Newly Acquired AIDS Patients During Antiretroviral Therapy. Journal of Kunming Medical University, 2021, 42(11): 159-165. doi: 10.12259/j.issn.2095-610X.S20211128
[14]	Ting-ting YU, Xiao-fei LI, Hong-ying WANG, Run-wu ZHANG, Cai-mei DING, Li-hua LI, Jing BAI, Dong-ling LI, Dong PU. Application of Viral Load Testing in Diagnosing 102 Cases of Indeterminate HIV Antibody. Journal of Kunming Medical University, 2020, 41(11): 130-133. doi: 10.12259/j.issn.2095-610X.S20201126
[15]	Zhang Le , Peng Jing , Xia Jia Wei , Yue Yun Xuan . . Journal of Kunming Medical University, 2018, 39(12): 115-119.
[16]	Ma Xue Ting , Li Ya . The Analysis of T Lymphocyte Subset Among Newly-discovered HIV Infectors and Patients. Journal of Kunming Medical University, 2017, 38(11): 112-117.
[17]	Liu Jun . . Journal of Kunming Medical University,
[18]	Liu Yue Bo . . Journal of Kunming Medical University,
[19]	Guo Xian Li . . Journal of Kunming Medical University,
[20]	Huang Qi . . Journal of Kunming Medical University,